MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit tumor growth of human triple negative breast cancer

References

Adams, B.D., Wali, V.B., Cheng, C.J., Inukai, S., Booth, C.J., Agarwal, S., Rimm, D.L., Gyorffy, B., Santarpia, L., Pusztai, L., et al. (2016). miR-34a silences c-SRC to attenuate tumor growth in triple negative breast cancer. Cancer Res. 76, 927–939.10.1158/0008-5472.CAN-15-2321Suche in Google Scholar

Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297.10.1016/S0092-8674(04)00045-5Suche in Google Scholar

Bartel, D.P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136,215–233.10.1016/j.cell.2009.01.002Suche in Google Scholar PubMed PubMed Central

Betel, D., Wilson, M., Gabow, A., Marks, D.S., and Sander, C. (2008). The microRNA.org resource: targets and expression. Nucleic Acids Res. 36, D149–D153.10.1093/nar/gkm995Suche in Google Scholar PubMed PubMed Central

Cerchietti, L.C., Yang, S.N., Shaknovich, R., Hatzi, K., Polo, J.M., Chadburn, A., Dowdy, S.F., and Melnick, A. (2009). A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo. Blood 113, 3397–3405.10.1182/blood-2008-07-168773Suche in Google Scholar PubMed PubMed Central

Enright, A.J., John, B., Gaul, U., Tuschl, T., Sander, C., and Marks, D.S. (2003). MicroRNA targets in Drosophila. Genome Biol. 5, R1.10.1186/gb-2003-5-1-r1Suche in Google Scholar PubMed PubMed Central

Feng, X., Zhao, L., Gao, S., Song, X., Dong, W., Zhao, Y., Zhou, H., Cheng, L., Miao, X., and Jia, L. (2016). Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4. Gene 578, 232–241.10.1016/j.gene.2015.12.028Suche in Google Scholar PubMed

Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., and Bray, F. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359–E386.10.1002/ijc.29210Suche in Google Scholar PubMed

Haga, C.L. and Phinney, D.G. (2012). MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network. J. Biol. Chem. 287, 42695–42707.10.1074/jbc.M112.387761Suche in Google Scholar PubMed PubMed Central

Haga, C.L., Velagapudi, S.P., Strivelli, J.R., Yang, W.Y., Disney, M.D., and Phinney, D.G. (2015). Small molecule inhibition of miR-544 biogenesis disrupts adaptive responses to hypoxia by modulating ATM-mTOR signaling. ACS Chem. Biol. 10, 2267–2276.10.1021/acschembio.5b00265Suche in Google Scholar PubMed PubMed Central

Jin, C., Yan, B., Lu, Q., Lin, Y., and Ma, L. (2016). Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development. Tumour Biol. 37, 7383–7394.10.1007/s13277-015-4605-6Suche in Google Scholar PubMed

Kwak, P.B., Iwasaki, S., and Tomari, Y. (2010). The microRNA pathway and cancer. Cancer Sci. 101, 2309–2315.10.1111/j.1349-7006.2010.01683.xSuche in Google Scholar PubMed

Lee, Y.S. and Dutta, A. (2009). MicroRNAs in cancer. Annu. Rev. Pathol. 4, 199–227.10.1146/annurev.pathol.4.110807.092222Suche in Google Scholar PubMed PubMed Central

Li, Y., Zhao, L., Shi, B., Ma, S., Xu, Z., Ge, Y., Liu, Y., Zheng, D., and Shi, J. (2015). Functions of miR-146a and miR-222 in tumor-associated macrophages in breast cancer. Sci. Rep. 5, 18648.10.1038/srep18648Suche in Google Scholar PubMed PubMed Central

Lo, P.K., Wolfson, B., Zhou, X., Duru, N., Gernapudi, R., and Zhou, Q. (2015). Noncoding RNAs in breast cancer. Brief Funct. Genomics. 37, 7383–7394.10.1093/bfgp/elv055Suche in Google Scholar PubMed PubMed Central

Lv, Z.D., Yang, Z.C., Liu, X.P., Jin, L.Y., Dong, Q., Qu, H.L., Li, F.N., Kong, B., Sun, J., Zhao, J.J., et al. (2016). Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer. J. Cell Mol. Med. doi: 10.1111/jcmm.12856.10.1111/jcmm.12856Suche in Google Scholar PubMed PubMed Central

Ma, R., Zhang, G., Wang, H., Lv, H., Fang, F., and Kang, X. (2012). Downregulation of miR-544 in tissue, but not in serum, is a novel biomarker of malignant transformation in glioma. Oncol. Lett. 4, 1321–1324.10.3892/ol.2012.918Suche in Google Scholar PubMed PubMed Central

Mao, L., Zhang, Y., Deng, X., Mo, W., Yu, Y., and Lu, H. (2015). Transcription factor KLF4 regulates microRNA-544 that targets YWHAZ in cervical cancer. Am. J. Cancer Res. 5, 1939–1953.Suche in Google Scholar

Marotta, L.L., Almendro, V., Marusyk, A., Shipitsin, M., Schemme, J., Walker, S.R., Bloushtain-Qimron, N., Kim, J.J., Choudhury, S.A., Maruyama, R., et al. (2011). The JAK2/STAT3 signaling pathway is required for growth of CD44⁺ CD24^- stem cell-like breast cancer cells in human tumors. J. Clin. Invest. 121, 2723–2735.10.1172/JCI44745Suche in Google Scholar PubMed PubMed Central

Mathe, A., Scott, R.J., and Avery-Kiejda, K.A. (2015). miRNAs and other epigenetic changes as biomarkers in triple negative breast cancer. Int. J. Mol. Sci. 16, 28347–28376.10.3390/ijms161226090Suche in Google Scholar PubMed PubMed Central

Maxmen A. (2012). The hard facts. Nature 485, S50–S51.10.1038/485S50aSuche in Google Scholar PubMed

Schneider, B.P., Winer, E.P., Foulkes, W.D., Garber, J., Perou, C.M., Richardson, A., Sledge, G.W., and Carey, L.A. (2008). Triple-negative breast cancer: risk factors to potential targets. Clin. Cancer Res. 14, 8010–8018.10.1158/1078-0432.CCR-08-1208Suche in Google Scholar PubMed

Schwickert, A., Weghake, E., Bruggemann, K., Engbers, A., Brinkmann, B.F., Kemper, B., Seggewiss, J., Stock, C., Ebnet, K., Kiesel, L., et al. (2015). microRNA miR-142-3p inhibits breast cancer cell invasiveness by synchronous targeting of WASL, integrin aV, and additional cytoskeletal elements. PLoS One 10, e0143993.10.1371/journal.pone.0143993Suche in Google Scholar PubMed PubMed Central

Shen, R., Wang, Y., Wang, C.X., Yin, M., Liu, H.L., Chen, J.P., Han, J.Q., and Wang, W.B. (2015). MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer. Am. J. Transl. Res. 7, 2115–2126.Suche in Google Scholar

Singh, R., Yadav, V., Kumar, S., and Saini, N. (2015). MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1. Sci. Rep. 5, 17454.10.1038/srep17454Suche in Google Scholar PubMed PubMed Central

Tashkandi, H., Shah, N., Patel, Y., and Chen, H. (2015). Identification of new miRNA biomarkers associated with HER2-positive breast cancers. Oncoscience 2, 924–929.10.18632/oncoscience.275Suche in Google Scholar PubMed PubMed Central

Walker, S.R. and Frank, D.A. (2015a). Targeting BCL6 and STAT3 in triple negative breast cancer: the one-two punch? Oncoscience 2, 912.10.18632/oncoscience.270Suche in Google Scholar PubMed PubMed Central

Walker, S.R., Nelson, E.A., Zou, L., Chaudhury, M., Signoretti, S., Richardson, A., and Frank, D.A. (2009). Reciprocal effects of STAT5 and STAT3 in breast cancer. Mol. Cancer Res. 7, 966–976.10.1158/1541-7786.MCR-08-0238Suche in Google Scholar PubMed

Walker, S.R., Liu, S., Xiang, M., Nicolais, M., Hatzi, K., Giannopoulou, E., Elemento, O., Cerchietti, L., Melnick, A., and Frank, D.A. (2015b). The transcriptional modulator BCL6 as a molecular target for breast cancer therapy. Oncogene 34, 1073–1082.10.1038/onc.2014.61Suche in Google Scholar PubMed PubMed Central

Wang, L., Jiang, C.F., Li, D.M., Ge, X., Shi, Z.M., Li, C.Y., Liu, X., Yin, Y., Zhen, L., Liu, L.Z., et al. (2016). MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1. Oncotarget 7, 2660–2671.10.18632/oncotarget.6545Suche in Google Scholar PubMed PubMed Central

Wu, Q., Liu, X., Yan, H., He, Y.H., Ye, S., Cheng, X.W., Zhu, G.L., Wu, W.Y., Wang, X.N., Kong, X.J., et al. (2014). B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cells. BMC Cancer 14, 418.10.1186/1471-2407-14-418Suche in Google Scholar PubMed PubMed Central

Wu, Z., Li, X., Cai, X., Huang, C., and Zheng, M. (2016). miR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting slug. Tumour Biol. 37, 7939–794010.1007/s13277-015-4665-7Suche in Google Scholar PubMed

Yu, J.M., Sun, W., Hua, F., Xie, J., Lin, H., Zhou, D.D., and Hu, Z.W. (2015). BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells. Cancer Lett. 365, 190–200.10.1016/j.canlet.2015.05.029Suche in Google Scholar PubMed

Zhi, Q., Guo, X., Guo, L., Zhang, R., Jiang, J., Ji, J., Zhang, J., Zhang, J., Chen, X., Cai, Q., et al. (2013). Oncogenic miR-544 is an important molecular target in gastric cancer. Anticancer Agents Med. Chem. 13, 270–275.10.2174/1871520611313020013Suche in Google Scholar PubMed

Zhou, S., Huang, Q., Zheng, S., Lin, K., You, J., and Zhang, X. (2016). miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis. Tumour Biol. 37, 6837–6845.10.1007/s13277-015-4500-1Suche in Google Scholar PubMed